Fig. 2From: Medulloblastoma therapy generates risk of a poorly-prognostic H3 wild-type subgroup of diffuse intrinsic pontine glioma: a report from the International DIPG RegistryDiagnosis and treatment with standard therapy of case 1, which included significant radiation to brainstem. a MR axial T2 FLAIR image of primary medulloblastoma diagnosed at age 8. b Radiation dose distribution showing craniospinal irradiation prescribed to 23.4Â Gy and posterior fossa boost prescribed to 32.4Â Gy. The brainstem is contoured in purple and received a mean dose of 50.1Â Gy. c MR axial T2 FLAIR image of DIPG diagnosed at age 21, 13Â years after treatment for primary medulloblastoma and in the area of the previously irradiated field. d MR spectroscopy with an elevated Chol/Cr ratio (1.66) that is consistent with malignancy (DIPG)Back to article page